Distinguished Lecture Series: Dr. James Nataro

  • March 2, 2009

Distinguished Lecture Series: Dr. James Nataro

“Vaccine Development in the Year 2100”

Dr. James Nataro

 

Cambridge University Communications Office:

Vaccines could eventually be developed which could prevent the deaths hundreds of thousands of children a year from diarrhoea, according to an international expert in infectious disease. Dr James P Nataro, a major researcher in vaccine development and global health, is speaking about the future of vaccine development in an open lecture on 2 March organised by the Gates Scholars Council. The lecture, ‘Vaccination in the Year 2100’, will focus on the future of his field, looking forward to the day when vaccines will elicit a more natural form of resistance to infectious diseases.

Dr Nataro’s lab at the University of Maryland focuses particularly on understanding the nature of Ecoli and finding ways of preventing its spread. The World Health Organization says Ecoli accounts for several hundred million cases of diarrhoea and several ten of thousand deaths each year. The lab is also involved in the development of vaccines against potential bioterror agents, especially plague. Dr Nataro is principal investigator on a $5.6m programme funded by the Bill & Melinda Gates Foundation to develop a faster and more precise test to diagnose the causes of diarrhoeal disease in developing countries, which account for at least 18% of deaths of children under five in the world. One of the main problems is identifying the particular pathogens that make children sick. Dr Nataro, who is a professor in the Departments of Pediatrics, Microbiology & Immunology, Biochemistry & Molecular Biology, and Medicine, says current tests for establishing the cause of diarrhoeal disease and therefore the best treatment are “cumbersome” and expensive and so not suited to developing countries. The programme’s goal is to develop mobile technology which allows the causes to be quickly and accurately diagnosed and could eventually lead to the development of suitable vaccines.

The talk took place on March 2, and part of the recording of this lecture is available in mp3 here: http://www.cl.cam.ac.uk/~pb400/DrNataro.mp3

 

Return to the Distinguished Lecture Series Online Calendar and Media Page here.

Latest News

Taking a broader lens to women and development

Tara Cookson’s research has always been ahead of the curve when it comes to women and development. Her PhD supervisor, Professor Sarah Radcliffe, called it “highly original”. Since leaving Cambridge Tara has continued to break new ground, founding the feminist research consultancy Ladysmith and taking up a Canada Research Chair in the School of Public […]

What makes humans unique?

Sara Sherbaji’s research explores fundamental questions of what makes humans unique and the role culture plays in our evolution. Her questions build on her Master’s dissertation, on her work as a psychology lab coordinator and on her experience of fleeing the Syrian war. She says:  “Since leaving Syria during the war, my goal has been […]

At the heart of global economic development policy

Charles Amo Yartey [2002] always wanted to follow in his father’s footsteps as an accountant. Growing up in Ghana, he applied to do Business Administration at university, but, because he had not studied business at school, he was offered Economics. It proved to be the start of a fascinating career at the centre of global […]

Are AI models as divided as we are?

Elections often reveal how deeply divided humanity can be. This year, as increasing polarisation continued to shape our world, we asked: Does this division transfer to our AI? Our journey to answer this question began in 2022, when we started our PhDs as Gates Cambridge Scholars. Two concurrent events captured this moment in history: the […]